Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells

Journal of Applied Toxicology

Volumn 34, Issue 4, 2014, Pages 373-379

  Turkez, Hasan ^a   Yousef, Mokhtar I ^b   Sönmez, Erdal ^c   Togar, Başak ^c   Bakan, Feray ^d   Sozio, Piera ^e   Stefano, Antonio Di ^e  

^a ERZURUM TECHNICAL UNIVERSITY   (Turkey)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c ATATÜRK UNIVERSITY   (Turkey)

^d SABANCI UNIVERSITY   (Turkey)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cytotoxicity; Genotoxicity; Hydroxyapatite; Lymphocyte; Oxidative stress

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 8 HYDROXYDEOXYGUANOSINE; DNA; HYDROXYAPATITE; HYDROXYAPATITE NANOPARTICLE; LACTATE DEHYDROGENASE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; ENZYME RELEASE; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MICRONUCLEUS; MICRONUCLEUS TEST; MTT ASSAY; OXIDATIVE STRESS; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

CYTOTOXICITY; GENOTOXICITY; HYDROXYAPATITE; LYMPHOCYTE; OXIDATIVE STRESS;

ANTIOXIDANTS; CELL SURVIVAL; CELLS, CULTURED; DEOXYGUANOSINE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DURAPATITE; HUMANS; LYMPHOCYTES; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MUTAGENICITY TESTS; NANOPARTICLES; OXIDATIVE STRESS; PRIMARY CELL CULTURE; SISTER CHROMATID EXCHANGE;

EID: 84893639369     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2958     Document Type: Article

References (46)

1. Albrecht C, Scherbart AM, van Berlo D, Braunbarth CM, Schins RPF, Scheel J. 2009. Evaluation of cytotoxic effects and oxidative stress with hydroxyapatite dispersions of different physicochemical properties in rat NR8383 cells and primary macrophages. Toxicol. In Vitro 23: 520-530.
2. Alom-Ruiz SP, Anilkumar N, Shah AM. 2008. Reactive oxygen species and endothelial activation. Antioxid. Redox Signal. 10: 1089-1100.
3. Cattaneo AG, Gornati R, Sabbioni E, Chiriva-Internati M, Cobos E, Jenkins MR, Bernardini G. 2010. Nanotechnology and human health: risks and benefits. J. Appl. Toxicol. 30: 730-744.
4. D'Aurizio E, Van Nostrum CF, Van Steenbergen MJ, Sozio P, Siepmann F, Siepmann J, Hennink WE, Di Stefano A. 2011. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug. Int. J. Pharm. 409: 289-296.
5. Di Stefano A, Sozio P, Iannitelli A, Cerasa LS. 2009. New drug delivery strategies for improved Parkinson's disease therapy. Expert Opin. Drug Deliv. 6: 389-404.
6. Di Stefano A, Iannitelli A, Laserra S, Sozio P. 2011. Drug delivery strategies for Alzheimer's disease treatment. Expert Opin. Drug Deliv. 8: 581-603.
7. Ding T, Xue Y, Lu H, Huang Z, Sun J. 2012. Effect of particle size of hydroxyapatite nanoparticles on its biocompatibility. IEEE Trans. Nanobiosci. 11: 336-340.
8. Dvir T, Timko BP, Kohane DS, Langer R. 2011. Nanotechnological strategies for engineering complex tissues. Nat. Nanotechnol. 6: 13-22.
9. ECETOC. 2006. Workshop on Testing Strategies to Establish the Safety of Nanomaterials. Barcelona, Workshop Report No. 7: 7-8.
10. Evans HJ, O'Riordan ML. 1975. Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. Mutat. Res. 31: 135-148.
11. Fan Q, Wang YE, Zhao X, Loo JS, Zuo YY. 2011. Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. ACS Nano 5: 6410-6416.
12. Gao L, Yang ST, Li S, Meng Y, Wang H, Lei H. 2013. Acute toxicity of zinc oxide nanoparticles to the rat olfactory system after intranasal instillation. J. Appl. Toxicol. 33(10): 1079-1088.
13. Hasegawa G, Shimonaka M, Ishihara Y. 2012. Differential genotoxicity of chemical properties and particle size of rare metal and metal oxide nanoparticles. J. Appl. Toxicol. 32: 72-80.
14. Iannitelli A, Grande R, di Stefano A, di Giulio M, Sozio P, Bessa LJ, Laserra S, Cellini L. 2011. Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm. Int. J. Mol. Sci. 12: 5039-5051.
15. IPCS. International Program on Chemical Safety. 1985. Environmental health criteria 46. Guidelines for the study of genetic effects in human populations. WHO: Geneva; 45-54.
16. Landi E, Celotti G, Logroscino G, Tampieri A. 2003. Carbonated hydroxyapatite as bone substitute. J. Eur. Ceram. Soc. 23: 2931-2937.
17. Li SQ, Zhu RR, Zhu H, Xue M, Sun XY, Yao SD, Wang SL. 2008. Nanotoxicity of TiO(2) nanoparticles to erythrocyte in vitro. Food Chem. Toxicol. 46: 3626-3231.
18. Liu X, Sun J. 2010. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kB pathways. Biomaterials 31: 8198-8209.
19. Liu Z, Liu S, Ren G, Zhang T, Yang Z. 2011. Nano-CuO inhibited voltage-gated sodium current of hippocampal CA1 neurons via reactive oxygen species but independent from G-proteins pathway. J. Appl. Toxicol. 31: 439-445.
20. Lu J, Liong M, Zink JI, Tamanoi F. 2007. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3: 1341-1346.
21. Meena R, Kesari KK, Rani M, Paulraj R. 2012. Effects of hydroxyapatite nanoparticles on proliferationand apoptosis of human breast cancer cells (MCF-7). J. Nanopart. Res. 14: 712.
22. Motskin M, Wright DM, Muller K, Kyle N, Gard TG, Porter AE, Skepper JN. 2009. Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability. Biomaterials 30: 3307-3317.
23. Oesterling E, Chopra N, Gavalas V, Arzuaga X, Lim EJ, Sultana R. 2008. Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicol. Lett. 178: 160-166.
24. Opacic-Galic V, Petrovic V, Zivkovic S, Jokanovic V, Nikolic B, Knezevic-Vukcevic J, Mitic-Culafic D. 2013. New nanostructural biomaterials based on active silicate systems and hydroxyapatite: characterization and genotoxicity in human peripheral blood lymphocytes. Int. Endod. J. 46: 506-516.
25. Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G. 2009. Gold nanoparticles of diameter 1.4nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5: 2067-2076.
26. Polyzois I, Nikolopoulos D, Michos I, Patsouris E, Theocharis S. 2012. Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J. Appl. Toxicol. 32: 255-269.
27. Rothen-Rutishauser B, Mühlfeld C, Blank F, Musso C, Gehr P. 2007. Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part. Fibre Toxicol. 4: 9.
28. Rumpel E, Wolf E, Kauschke E, Bienengraber V, Bayerlein T, Gedrange T, Proff P. 2006. The biodegradation of hydroxyapatite bone graft substitutes in vivo. Folia Morphol. (Warsz). 65: 43-48.
29. Schanen BC, Karakoti AS, Seal S, Drake 3rd DR, Warren WL, Self WT. 2009. Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano 3: 2523-2532.
30. Scheel J, Herman M. 2011. Integrated risk assessment of a hydroxyapatite-protein-composite for use in oral care products: A weight-of-evidence case study. Regul. Toxicol. Pharmacol. 59: 310-323.
31. Schins RP, Lightbody JH, Borm PJ, Shi T, Donaldson K, Stone V. 2004. Inflammatory effects of coarse and fine particulate matter in relation to chemical and biological constituents. Toxicol. Appl. Pharmacol. 195: 1-11.
32. Schmid O, Moller W, Semmler-Behnke M, Ferron G.A, Karg E, Lipka J, Schulz H, Kreyling WG, Stoeger T. 2009. Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers 14: 67-73.
33. Schwarze PE, Ovrevik J, Hetland RB, Becher R, Cassee FR, Lag M, Lovik M, Dybing E, Refsnes M. 2007. Importance of size and composition of particles for effects on cells in vitro. Inhal. Toxicol. 19: 17-22.
34. Sha B, Gao W, Wang S, Gou X, Li W, Liang X, Qu Z, Xu F, Lu TJ. 2013. Oxidative stress increased hepatotoxicity induced by nano-titanium dioxide in BRL-3A cells and Sprague-Dawley rats. J. Appl. Toxicol. (in press). DOI: 10.1002/jat.2900. [Epub ahead of print]
35. Simbula G, Columbano A, Ledda-Columbano GM, Sanna L, Deidda M, Diana A. 2007. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 12: 113-123.
36. Singh SP, Kumari M, Kumari SI, Rahman MF, Mahboob M, Grover P. 2013. Toxicity assessment of manganese oxide micro and nanoparticles in Wistar rats after 28days of repeated oral exposure. J. Appl. Toxicol. 33(10): 1165-1179.
37. Song Y, Li X, Du X. 2009. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur. Respir. J. 34: 559-567.
38. Turkez H. 2008. Effects of boric acid and borax on titanium dioxide genotoxicity. J. Appl. Toxicol. 28: 658-664.
39. Turkez H. 2011. The role of ascorbic acid on titanium dioxide-induced genetic damage assessed by the comet assay and cytogenetic tests. Exp. Toxicol. Pathol. 63: 453-457.
40. Turkez H, Geyikoglu F. 2010. Boric acid: a potential chemoprotective agent against aflatoxin b(1) toxicity in human blood. Cytotechnology 62: 157-165.
41. Turkez H, Togar B. 2010. The genotoxic and oxidative damage potential of olanzapine in vitro. Toxicol. Ind. Health 26: 583-588.
42. Turkez H, Aydin E, Aslan A. 2012. Xanthoria elegans (Link) (lichen) extract counteracts DNA damage and oxidative stress of mitomycin C in human lymphocytes. Cytotechnology 64: 679-686.
43. Turkez H, Celik K, Cakmak B. 2013a. Biosafety evaluation of nanoparticles in view of genotoxicity and carcinogenicity studies: A systematic review. Key Eng. Mater. 543: 200-203.
44. Turkez H, Cakmak B, Celik K. 2013b. Evaluation of the potential in vivo genotoxicity of tungsten (VI) oxide nanopowder for human health. Key Eng. Mater. 543: 89-92.
45. Wang A, Pu K, Dong B, Liu Y, Zhang L, Zhang Z, Duan W, Zhu Y. 2013. Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. J. Appl. Toxicol. 33(10): 1156-1164.
46. Xu Z, Liu C, Wei J, Sun J. 2012. Effects of four types of hydroxyapatite nanoparticles with different nanocrystal morphologies and sizes on apoptosis in rat osteoblasts. J. Appl. Toxicol. 32: 429-435.